Share-Based Payment (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
| Share-Based Payment [Abstract] |
|
| Schedule of Number of Share Options and their Related Weighted Average Exercise Prices |
Movements in the number of share options
and their related weighted average exercise prices (in dollars) during the years ended December 31, 2025, 2024 and 2023 are as follows:
| | |
Year ended December 31, | |
| | |
2025 | | |
2024 | | |
2023 | |
| | |
Number of options | | |
Weighted average exercise price (USD) | | |
Number of options | | |
Weighted average exercise price (USD) | | |
Number of options | | |
Weighted average exercise price (USD) | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
| Outstanding at beginning of year | |
| 27,100,000 | | |
| 0.03 | | |
| 12,550,000 | | |
| 0.05 | | |
| 12,400,000 | | |
| 0.05 | |
| Granted | |
| 94,600,000 | | |
| 1.47 | | |
| 14,850,000 | | |
| 0.01 | | |
| 150,000 | | |
| 0.01 | |
| Expired | |
| (2,100,000 | ) | |
| 0.55 | | |
| (300,000 | ) | |
| 0.12 | | |
| - | | |
| - | |
| Forfeited | |
| (1,500,000 | ) | |
| 0.04 | | |
| | | |
| | | |
| | | |
| | |
| | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| Outstanding at end of year | |
| 118,100,000 | | |
| 1.17 | | |
| 27,100,000 | | |
| 0.03 | | |
| 12,550,000 | | |
| 0.05 | |
| | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| Exercisable at end of year | |
| 75,289,083 | | |
| 1.08 | | |
| 23,462,500 | | |
| 0.03 | | |
| 12,550,000 | | |
| 0.05 | |
|
| Schedule of Exercise Price and Remaining Contractual Life for Options Outstanding |
Below is information about the exercise
price (in dollars) and the remaining contractual life (in years) for options outstanding at end of year:
| December 31, | | | 2025 | | | 2024 | | Options outstanding at end of year | | | Range of exercise prices (USD) | | | Weighted average remaining contractual life | | | Options outstanding at end of year | | | Range of exercise prices (USD) | | | Weighted average remaining contractual life | | | | | | | | | | | | | | | | | | | | | | 23,500,000 | | | | 0.04-0.09 | | | | 3.59 | | | | 10,150,000 | | | | 0.03 - 0.11 | | | | 5.30 | | | | 94,600,000 | | | | 0.012-0.016 | | | | 9.21 | | | | 37,012,500 | | | | 0.17 | | | | 0.66 | | | | | | | | | | | | | | | | 15,450,000 | | | | 0.01 | | | | 4.25 | | | | | | | | | | | | | | | | | | | | | | | | | | | | 118,100,000 | | | | | | | | | | | | 62,612,500 | | | | | | | | | | | December 31, 2023 | | Options outstanding at end of year | | | Range of exercise prices (USD) | | | Weighted average remaining contractual life | | | | | | | | | | | | | 10,900,000 | | | | 0.03 - 0.14 | | | | 6.07 | | | | 1,500,000 | | | | 0.17 | | | | 1.66 | | | | 150,000 | | | | 0.01 | | | | 9.17 | | | | | | | | | | | | | | | | 12,550,000 | | | | | | | | | |
|
| Schedule of Outstanding Options |
The table below summarizes the outstanding
options as of December 31, 2025 that have been granted to the Company’s executives, directors and consultants Options outstanding | | | Position | | Grant date (*) | | Exercise price in NIS | | | | | | Fair value USD in thousands | | | Vesting schedule | | | | | | | | | | | | | | | | | | | | | 10,000,000 | | | Former Chief Executive Officer | | July 7, 2020 | | | 0.09 | | | | | | | | 103 | | | Fully vested | | | 150,000 | | | Director | | March 2, 2023 | | | 0.0495 | | | | | | | | 1 | | | Fully vested | | | 500,000 | | | Chief Financial Officer | | March 17, 2024 | | | 0.0438 | | | | | | | | 3 | | | 12 equal portions each quarter over a period of 3 years from the date of grant | | | 1,000,000 | | | Director | | March 17, 2024 | | | 0.0438 | | | | | | | | 21 | | | 12 equal portions each quarter over a period of 3 years from the date of grant | | | 10,000,000 | | | Chief Executive Officer | | March 17, 2024 | | | 0.0438 | | | | | | | | 214 | | | Fully vested on date of grant | | | 850,000 | | | Director | | March 17, 2024 | | | 0.0438 | | | | | | | | 18 | | | 12 equal portions each quarter over a period of 3 years from the date of grant | | | 1,000,000 | | | Director | | March 17, 2024 | | | 0.0438 | | | | | | | | 22 | | | 12 equal portions each quarter over a period of 3 years from the date of grant | | | 42,300,000 | | | Chief Executive Officer | | July 21, 2025 | | | 0.04 | | | | 46 | | | | 441 | | | 16 equal portions each month from the date of grant | | | 42,300,000 | | | Chief Executive Officer and Director | | July 21, 2025 | | | 0.0510 | | | | | | | | 433 | | | Subject to performance conditions which were not met; accordingly, the options did not vest. | | | 10,000,000 | | | Director | | July 21, 2025 | | | 0.038 | | | | | | | | 106 | | | Fully vested on date of grant | | | | | | | | | | | | | | | | | | | | | | | | | 118,100,000 | | | | | | | | | | | | | | | | | | | |
|
| Schedule of Fair Value for Options Granted |
The fair value for options granted
in 2025 is estimated at the date of grant using a Black-Scholes model with the following weighted average assumptions:
| | | April 7, 2025 | | | July 21, 2025 | | | | | | | | | | | Dividend yield | | | 0 | % | | | 0 | % | | Expected volatility | | | 112.50 | % | | | 112.50 | % | | Risk-free interest | | | 4.17 | % | | | 4.17 | % | | Expected life (years) | | | 5 | | | | 5 | | The fair value for options granted
in 2024 is estimated at the date of grant using a Black-Scholes model with the following weighted average assumptions:
| | | March 17, 2024 | | | April 30, 2024 | | | | | | | | | | | Dividend yield | | | 0 | % | | | 0 | % | | Expected volatility | | | 81.27 | % | | | 91.15 | % | | Risk-free interest | | | 4.31 | % | | | 4.72 | % | | Expected life (years) | | | 5 | | | | 5 | | The fair value for options granted
in 2023 is estimated at the date of grant using a Black-Scholes model with the following weighted average assumptions:
| | | March 2, 2023 | | | | | | | | Dividend yield | | | 0 | % | | Expected volatility | | | 67.5 | % | | Risk-free interest | | | 4.08 | % | | Expected life (years) | | | 10 | |
|